Inventor · disambiguated record
Jiong Lan
Also filed as: LAN JIONG
36 granted patents·30 pending applications·333 citations·filing 2004–2023
97Inventor score
Files withGENFLEET THERAPEUTICS SHANGHAI INC18SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD13NOVARTIS AG6BURGER MATTHEW5BURGER MATTHEW T4
Top patents by PatentIndex Score
66 records- 0195US8168794B2Pim kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2009·Granted May 1, 2012·36 cites·14 claims
- 0295US7569571B2Substituted pyrazolo [3,4-d]pyrimidines as cytokine modulatorsNOVARTIS AG·Filed 2004·Granted Aug 4, 2009·104 cites·5 claims
- 0394US8329732B2Kinase inhibitors and methods of their useBURGER MATTHEW T·Filed 2009·Granted Dec 11, 2012·36 cites·21 claims
- 0490US9527851B2Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2012·Granted Dec 27, 2016·17 cites·21 claims
- 0590US7553854B26-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signalingNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Granted Jun 30, 2009·20 cites·78 claims
- 0689US8822497B2PIM kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2008·Granted Sep 2, 2014·10 cites·9 claims
- 0789US8592455B2Kinase inhibitors and methods of their useBURGER MATTHEW T·Filed 2011·Granted Nov 26, 2013·11 cites·8 claims
- 0888US10428074B2Pyrrole heteroaryl ring derivative and method of use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Oct 1, 2019·6 cites·23 claims
- 0987US8829193B2PIM kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2012·Granted Sep 9, 2014·5 cites·11 claims
- 1087US8173657B2Imidazoquinoxaline compounds as immunomodulatorsSUTTON JAMES·Filed 2007·Granted May 8, 2012·5 cites·27 claims
- 1186US12054497B2Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Granted Aug 6, 2024·3 cites·20 claims
- 1286US8710048B26-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signalingSUTTON JAMES C·Filed 2012·Granted Apr 29, 2014·12 cites·28 claims
- 1385US7754726B2Benzamide derivatives as p-38 kinase inhibitorsNOVARTIS AG·Filed 2004·Granted Jul 13, 2010·20 cites·13 claims
- 1482US10100047B2Piperidine derivatives as orexin receptor antagonistSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Oct 16, 2018·5 cites·10 claims
- 1582US9079889B2Kinase inhibitors and methods of their useBURGER MATTHEW T·Filed 2013·Granted Jul 14, 2015·4 cites·2 claims
- 1682US8410160B25-membered heterocycle-based P38 kinase inhibitorsFRYSZMAN OLGA M·Filed 2012·Granted Apr 2, 2013·6 cites·14 claims
- 1782US7728009B1Thiazole amides, imidazole amides and related analoguesNEUROGEN CORP·Filed 2006·Granted Jun 1, 2010·6 cites·18 claims
- 1879US10815197B2N-sulfonyl benzamides as voltage-gated sodium channel inhibitorsSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Oct 27, 2020·2 cites·2 claims
- 1979US9388133B2Pyrrole sulfonamide derivative, preparation method for same, and medical application thereofJIANGSU HANSOH PHARMACEUTICAL CO LTD·Filed 2013·Granted Jul 12, 2016·5 cites·21 claims
- 2078US11155546B24,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivatives and uses thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Oct 26, 2021·1 cites·19 claims
- 2177US10435400B22,4-disubstituted phenylene-1,5-diamine derivatives and applications thereof, and pharmaceutical compositions and pharmaceutically acceptable compositions prepared therefromSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Oct 8, 2019·3 cites·9 claims
- 2276US9637484B2Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereofShanghai hengrui pharmaceutical co ltd·Filed 2014·Granted May 2, 2017·5 cites·20 claims
- 2375US8580838B25-membered heterocycle-based p38 kinase inhibitorsNOVARTIS AG·Filed 2013·Granted Nov 12, 2013·2 cites·14 claims
- 2472US10577346B2Benzobicycloalkane derivatives, their preparation and pharmaceutical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Mar 3, 2020·1 cites·19 claims
- 2572US8242117B25-membered heterocycle-based p38 kinase inhibitorsFRYSZMAN OLGA M·Filed 2010·Granted Aug 14, 2012·2 cites·14 claims
- 2672US7863314B25-membered heterocycle-based p38 kinase inhibitorsNOVARTIS AG·Filed 2004·Granted Jan 4, 2011·4 cites·7 claims
- 2766US10561646B2EGFR inhibitor and pharmaceutically acceptable salt and polymorph thereof, and use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2016·Granted Feb 18, 2020·1 cites·15 claims
- 2863US12384774B2Polymorph of CDK9 inhibitor and preparation method for polymorph and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Granted Aug 12, 2025·0 cites·21 claims
- 2963US9879008B22,3,4,6-tetra-substituted benzene-1,5-diamine derivatives, preparation method therefor and medicinal use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Jan 30, 2018·1 cites·10 claims
- 3061US2025145632A1Pyrimidine Heterocyclic Compound, Preparation Method Thereof and use Thereof in MedicineINSILICO MEDICINE IP LTD·Filed 2022·Application pending·0 cites
- 3159US2024352040A1Crystal form of ripk1 inhibitor, acid salt thereof, and crystal form of acid salt thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 3259US2009264409A1Bicyclic Heterocyclic p-38 Kinase InhibitorsDONG QING·Filed 2009·Application pending·0 cites
- 3358US2025221989A1Pharmaceutical composition, use thereof, and method for treating cancerGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2023·Application pending·0 cites
- 3458US2024158417A1Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2023·Application pending·0 cites
- 3557US2024294523A1Heterocyclic lactam compound, and preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 3656US11174254B2Aniline-substituted 1,2-dihydropyrrol[3,4-C]pyridin/pyrimidin-3-one derivative and use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2018·Granted Nov 16, 2021·0 cites·12 claims
- 3756US7700622B2p-38 kinase inhibitorsNOVARTIS AG·Filed 2004·Granted Apr 20, 2010·0 cites·19 claims
- 3856US2025051333A1Polymorph of kras inhibitor, preparation method therefor, and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 3955US8759338B2Heterocyclic kinase inhibitorsBURGER MATTHEW·Filed 2009·Granted Jun 24, 2014·0 cites·10 claims
- 4055US2013101622A1Imidazoquinoxaline compounds as immunomodulatorsSUTTON JAMES·Filed 2012·Application pending·0 cites
- 4155US2024270758A1Pyridino-or pyrimido-cyclic compound, preparation method therefor and medical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 4254US2025084078A1Fused ring-substituted six-membered heterocyclic compound, and preparation method therefor and use thereofGENFLEFT THERAPEUTICS SHANGHAI INC·Filed 2023·Application pending·0 cites
- 4353US2025186456A1Pyrimidine-fused cyclic compound and preparation method and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 4451US2024174691A1Pyrimidine-fused cyclic compound, preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 4551US2014249135A1Pim kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2014·Application pending·0 cites
- 4651US2015315150A1Kinase inhibitors and methods of their useBURGER MATTHEW T·Filed 2015·Application pending·0 cites
- 4750US2017044171A1Compounds for preparing pyrrole six-membered heteroaryl ring derivativeJIANGSU HENGRUI MEDICINE CO·Filed 2016·Application pending·0 cites
- 4849US2024360154A1Aroyl substituted tricyclic compound, preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2021·Application pending·0 cites
- 4949US2024182465A1Fused ring substituted six-membered heterocyclic compound, preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 5049US2010311729A1Substituted imidazopyridazines and pyrrolopyrimidines as lipid kinase inhibitorsCAPRARO HANS-GEORG·Filed 2008·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jiong Lan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →